The Business Of Neurotech

16 Episodes

Reverse

Daniel Månsson Talks tDCS, Depression and Scaling a Start Up

2026-11-0235:13

Flow Neuroscience has developed an at-home brain stimulation treatment for depression, but bringing it to market has involved years of clinical research, regulatory approvals, and commercial challenges. In this episode of the Business of Neurotech Podcast, host Adam Fraser welcomes Daniel Månsson, Co-founder and CEO of Flow Neuroscience, to explore the story behind the technology and the company's expansion into the U.S. market. Daniel explains how his background in clinical psychology led hi...

Chay Carter Talks Neurotech Recruitment and Market Trends

2026-10-1939:52

What can the people building neurotech teams tell us about where the industry is heading? In this episode of The Business of Neurotech, Adam Fraser speaks with Chay Carter, founder of Carter Sciences and co-founder of reccy neuro, to offer a recruitment-focused view of the sector. Chay brings decades of experience in recruitment and psychology, combining specialist hiring with research, newsletters and insights from the people developing the technology. In their conversation, Chay shares how ...

Paul Le Floch talks BCI, Coma and Start Up Dynamics

2026-10-0538:11

How can softer materials make implantable brain-computer interfaces safer, more stable and clinically useful? In this episode of The Business of Neurotech, Adam Fraser is joined by Dr Paul Le Floch, co-founder and CEO of Axoft, to explore how his materials science background led to Fleuron, a soft neural interface platform designed to reach deep brain regions while maintaining high-density recordings. Dr Le Floch explains why Axoft is initially focusing on disorders of consciousness, how the ...

Jordan DeKraker Talks Seed Funding, Brain AI and Epilepsy

2026-09-2138:55

How can academic brain-imaging research become a practical clinical tool for people with drug-resistant epilepsy? In this episode of The Business of Neurotech, Adam Fraser is joined by Jordan DeKraker, co-founder and CEO of BrainScores and a postdoctoral researcher at the Montreal Neurological Institute, to discuss how he went from hippocampal mapping to building an AI-enabled neuroimaging company. In their conversation, Jordan talks about how his personal experience with epilepsy sharpened t...

Matt Angle Talks Paradromics and BCI Market Dynamics

2026-09-0743:02

For people who have lost the ability to speak, brain-computer interfaces (BCIs) could open a new path back to communication. In this episode, Adam Fraser speaks with Matt Angle, founder and CEO of Paradromics, about the company’s 11-year journey to build a BCI that can restore communication for people who have lost it. Matt explains why moving more neural data is central to BCI performance and how Paradromics is approaching safety, durability and clinical translation. He breaks down why speec...

#box-pro-ellipsis-179421030302160{-webkit-line-clamp:2;}The Business Of Neurotech